FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Vande Woude

Research Profile

Living Beings

Chemicals & Drugs

Genes & Molecular Sequences

Anatomy

Disorders

Physiology

Signal Transduction

Concepts & Ideas

Co-author Network

Publications

TOP 3
Qian Xie; George Vande Woude; Michael E Berens
RTK inhibition: looking for the right pathways toward a miracle.
Brian J Nickoloff; George Vande Woude
Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma.
Alex Kentsis; Andrew L Kung; Jeffery L Kutok; Jonathan D Licht; Richard J Byers; James G Christensen; Amanda Christie; Suzanne E Dahlberg; Ruud Delwel; Lisa A Moreau; Vu Ngo; Casie Reed; Kim L Rice; Scott J Rodig; Takaomi Sanda; Louis M Staudt; Eleni Tholouli; Peter J M Valk; George Vande Woude; A Thomas Look
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Vande Woude (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Qian Xie; George Vande Woude; Michael E Berens
RTK inhibition: looking for the right pathways toward a miracle.
Future oncology (London, England) 2012;8(11):1397-400.
2012: Brian J Nickoloff; George Vande Woude
Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma.
Pigment cell & melanoma research 2012;25(6):758-61.
2012: Alex Kentsis; Andrew L Kung; Jeffery L Kutok; Jonathan D Licht; Richard J Byers; James G Christensen; Amanda Christie; Suzanne E Dahlberg; Ruud Delwel; Lisa A Moreau; Vu Ngo; Casie Reed; Kim L Rice; Scott J Rodig; Takaomi Sanda; Louis M Staudt; Eleni Tholouli; Peter J M Valk; George Vande Woude; A Thomas Look
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.
Nature medicine 2012;18(7):1118-22.
2012: Ermanno Gherardi; Carmen Birchmeier; Walter Birchmeier; George Vande Woude
Targeting MET in cancer: rationale and progress.
Nature reviews. Cancer 2012;12(2):89-103.
2012: Qian Xie; Andrea Worschech; Dafna W Kaufman; Lisa Kefene; Julie Koeman; Mark A Enter; Yanli Su; Tom DeKoning; Valeria De Giorgi; Francesco M Marincola; Robert Bradley; Ena Wang; Maria Libera Ascierto; Timothy J O'Rourke; Liang Kang; Curt Essenburg; George Vande Woude
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(2):570-5.
2012: Yu-Wen Zhang; Karl J Dykema; Kyle A Furge; Ben Staal; George Vande Woude
Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
PloS one 2012;7(6):e38955.
2011: Kenneth L. Scott; Remco van Doorn; George Vande Woude; Chang-Jiun Wu; Yonghong Xiao; Rhamy Zeid; Marcus W Bosenberg; Lisa A Cameron; Gerald Chu; Ronald A DePinho; Sabin Dhakal; Tamar Feinberg; Scott R Granter; Jason A Hanna; Timothy P Heffernan; Mariela Jaskelioff; Minjung Kim; Chengyin Min; Cristina Nogueira; Samuel R Perry; David L Rimm; Lynda Chin
Proinvasion metastasis drivers in early-stage melanoma are oncogenes.
Cancer cell 2011;20(1):92-103.
2011: Qian Xie; Robert Wondergem; Yuehai Shen; Greg Cavey; Jiyuan Ke; Ryan Thompson; Robert Bradley; Jennifer Daughtery-Holtrop; Yong Xu; Edwin Chen; Hanan Omar; Neal Rosen; David Wenkert; H Eric Xu; Jennifer Daugherty-Holtrop; George Vande Woude
Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(10):4105-10.
2010: M Kanai; M S Crowe; Y Zheng; George Vande Woude; K Fukasawa
RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.
Oncogene 2010;29(45):6040-50.
2010: Yu-Wen Zhang; Ben Staal; Curt Essenburg; Yanli Su; Liang Kang; Rich West; Dafna Kaufman; Tom Dekoning; Bryn Eagleson; Sean G Buchanan; George Vande Woude
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.
Cancer research 2010;70(17):6880-90.
2010: Marianne K Melnik; Craig Webb; Patrick J Richardson; Charles R Luttenton; Alan D Campbell; Thomas J Monroe; Timothy J O'Rourke; Kathleen J Yost; Connie M Szczepanek; Michelle R Bassett; Kimberly J Truszkowski; Phyllis Stein; Matthew W Van Brocklin; Alan T Davis; Gabriela Bedolla; George Vande Woude; Han-Mo Koo
Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.
Molecular cancer therapeutics 2010;9(8):2423-9.
2010: W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Structural basis for agonism and antagonism of hepatocyte growth factor.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(30):13264-9.
2010: Nigel Paneth; George Vande Woude; Eric Kort
Screening and detection of breast cancer and prostate cancer.
JAMA : the journal of the American Medical Association 2010;303(11):1032-3; author reply 1033-4.
2010: Carrie R Graveel; Jack D DeGroot; Robert E Sigler; George Vande Woude
Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles.
PloS one 2010;5(10):e13586.
2009: Chong-Feng Gao; Qian Xie; Yu-Wen Zhang; Yanli Su; Ping Zhao; Brian Cao; Kyle A Furge; Jan Sun; Karen Rex; Tao Osgood; Angela Coxon; Teresa L Burgess; George Vande Woude
Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
Molecular cancer therapeutics 2009;8(10):2803-10.
2009: Eric J Kort; Nigel Paneth; George Vande Woude
The decline in U.S. cancer mortality in people born since 1925.
Cancer research 2009;69(16):6500-5.
2009: Carrie R Graveel; Jack D DeGroot; Yanli Su; Julie Koeman; Karl Dykema; Samuel Leung; Jacqueline Snider; Sherri R Davies; Pamela J Swiatek; Sandra Cottingham; Mark A Watson; Matthew J Ellis; Robert E Sigler; Kyle A Furge; George Vande Woude
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):12909-14.
2009: Matthew W Vanbrocklin; James P Robinson; Todd Whitwam; Adam R Guilbeault; Julie Koeman; Pamela J Swiatek; George Vande Woude; Joseph D Khoury; Sheri L Holmen
Met amplification and tumor progression in Cdkn2a-deficient melanocytes.
Pigment cell & melanoma research 2009;22(4):454-60.
2009: Jae Wook Jeong; Hee Sun Lee; Kevin Y Lee; Lisa D White; Russell R Broaddus; Yu-Wen Zhang; George Vande Woude; Linda C Giudice; Steven L Young; Bruce A Lessey; Sophia Y Tsai; John P Lydon; Francesco J DeMayo
Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(21):8677-82.
2009: Joseph Paul Eder; George Vande Woude; Scott A Boerner; Patricia M LoRusso
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2207-14.
2009: Beatrice S Knudsen; Ping Zhao; James Resau; Sandra Cottingham; Ermanno Gherardi; Eric Xu; Bree Berghuis; Jennifer Daugherty; Tessa Grabinski; Jose Toro; Troy A. Giambernardi; R Scot Skinner; Milton D Gross; Eric Hudson; Eric Kort; Ernst Lengyel; Aviva Ventura; Richard A West; Qian Xie; Rick Hay; George Vande Woude; Brian Cao
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2009;17(1):57-67.
2008: Cecile Rouleau; Krishna Menon; Paula Boutin; Cheryl Guyre; Hitoshi Yoshida; Shiro Kataoka; Michael Perricone; Srinivas Shankara; Arthur E Frankel; Nicholas S Duesbery; George Vande Woude; Hans-Peter Biemann; Beverly A Teicher
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
International journal of oncology 2008;32(4):739-48.
2008: Beatrice S Knudsen; George Vande Woude
Showering c-MET-dependent cancers with drugs.
Current opinion in genetics & development 2008;18(1):87-96.
2008: Qian Xie; Ryan Thompson; Kim Hardy; Lisa DeCamp; Bree Berghuis; Robert Sigler; Beatrice Knudsen; Sandra Cottingham; Ping Zhao; Karl Dykema; Brian Cao; James Resau; Rick Hay; George Vande Woude
A highly invasive human glioblastoma pre-clinical model for testing therapeutics.
Journal of translational medicine 2008;6():77.
2008: George Klein; George Vande Woude
Advances in Cancer Research: Centennial Volume. Introduction.
Advances in cancer research 2008;100():v-vii.
2007: Ping Zhao; Tessa Grabinski; Chongfeng Gao; R Scot Skinner; Troy A. Giambernardi; Yanli Su; Eric Hudson; James Resau; Milton D Gross; George Vande Woude; Rick Hay; Brian Cao
Identification of a met-binding peptide from a phage display library.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6049-55.
2007: W David Tolbert; Jennifer Daugherty; ChongFeng Gao; Qian Xie; Cindy Miranti; Ermanno Gherardi; George Vande Woude; H Eric Xu
A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(37):14592-7.
2007: Kristina Lindemann; James Resau; J Nährig; Eric J Kort; B Leeser; K Annecke; Anita Welk; J Schäfer; George Vande Woude; Ernst Lengyel; Nadia Harbeck
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
Histopathology 2007;51(1):54-62.
2007: ChongFeng Gao; Kyle A Furge; Julie Koeman; Karl J Dykema; Yanli Su; Mary Lou Cutler; Adam Werts; Peterson Haak; George Vande Woude
Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8995-9000.
2007: Yu-Wen Zhang; George Vande Woude
Mig-6, signal transduction, stress response and cancer.
Cell cycle (Georgetown, Tex.) 2007;6(5):507-13.
2007: Kenjiro Sawada; Amir Reza Radjabi; Nariyoshi Shinomiya; Emily O Kistner; Hilary Kenny; Amy R Becker; Muge Turkyilmaz; Ravi Salgia; S Diane Yamada; George Vande Woude; Maria Tretiakova; Ernst Lengyel
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
Cancer research 2007;67(4):1670-9.
2007: Yu-Wen Zhang; B Staal; Yanli Su; Pamela Swiatek; Ping Zhao; Brian Cao; James Resau; R Sigler; R Bronson; George Vande Woude
Evidence that MIG-6 is a tumor-suppressor gene.
Oncogene 2007;26(2):269-76.
2006: Jae-Ho Lee; Chong-Feng Gao; Chong-Chou Lee; Myung Deok Kim; George Vande Woude
An alternatively spliced form of Met receptor is tumorigenic.
Experimental & molecular medicine 2006;38(5):565-73.
2006: Sharon Moshitch-Moshkovitz; Galia Tsarfaty; Dafna W Kaufman; Gidi Stein; Keren Shichrur; Eddy Solomon; Robert H Sigler; James Resau; George Vande Woude; Ilan Tsarfaty
In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.
Neoplasia (New York, N.Y.) 2006;8(5):353-63.
2006: Galia Tsarfaty; Gidi Stein; Sharon Moshitch-Moshkovitz; Dafna W Kaufman; Brian Cao; James Resau; George Vande Woude; Ilan Tsarfaty
HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.
Neoplasia (New York, N.Y.) 2006;8(5):344-52.
2006: Nicholas S Duesbery; George Vande Woude
BRAF and MEK mutations make a late entrance.
Science's STKE : signal transduction knowledge environment 2006;2006(328):pe15.
2006: Ermanno Gherardi; Sara Sandin; Maxim V Petoukhov; John Finch; Mark E Youles; Lars-Göran Ofverstedt; Ricardo N Miguel; Tom L Blundell; George Vande Woude; Ulf Skoglund; Dmitri I Svergun
Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(11):4046-51.
2005: Randal P Orchekowski; Darren Hamelinck; Lin Li; Ewa Gliwa; Matt vanBrocklin; Jorge A Marrero; George Vande Woude; Ziding Feng; Randall Brand; Brian B Haab
Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.
Cancer research 2005;65(23):11193-202.
2005: Rick V Hay; Brian Cao; R Scot Skinner; Yanli Su; Ping Zhao; Margaret Gustafson; Chao-Nan Qian; Bin Tean Teh; Beatrice S Knudsen; James Resau; Shuren Shen; David J Waters; Milton D Gross; George Vande Woude
Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek).
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7064s-7069s.
2005: Yi Ren; Brian Cao; Simon Law; Yi Xie; Ping-Yin Lee; Leo Cheung; Yongxong Chen; Xin Huang; Hiu Man Chan; Ping Zhao; John Luk; George Vande Woude; John Wong
Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6190-7.
2005: Yu-Wen Zhang; Yanli Su; Nathan Lanning; Pamela Swiatek; Roderick T Bronson; Robert Sigler; Richard W Martin; George Vande Woude
Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(33):11740-5.
2005: Yuehai Shen; Qian Xie; Monica Norberg; Edward A Sausville; George Vande Woude; David Wenkert
Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.
Bioorganic & medicinal chemistry 2005;13(16):4960-71.
2005: Chong-Feng Gao; Qian Xie; Yan-Li Su; Julie Koeman; Sok Kean Khoo; Margaret Gustafson; Beatrice S Knudsen; Rick Hay; Nariyoshi Shinomiya; George Vande Woude
Proliferation and invasion: plasticity in tumor cells.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(30):10528-33.
2005: Qian Xie; Chong-Feng Gao; Nariyoshi Shinomiya; Edward A Sausville; Rick Hay; Margaret Gustafson; Yuehai Shen; David Wenkert; George Vande Woude
Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.
Oncogene 2005;24(23):3697-707.
2005: Carrie R Graveel; Cheryl A London; George Vande Woude
A mouse model of activating Met mutations.
Cell cycle (Georgetown, Tex.) 2005;4(4):518-20.
2005: Azharul Islam; Yoko Sakamoto; Kazuhisa Kosaka; Satoshi Yoshitome; Isamu Sugimoto; Kazuo Yamada; Ellen Shibuya; George Vande Woude; Eikichi Hashimoto
The distinct stage-specific effects of 2-(p-amylcinnamoyl)amino-4-chlorobenzoic acid on the activation of MAP kinase and Cdc2 kinase in Xenopus oocyte maturation.
Cellular signalling 2005;17(4):507-23.
2005: Ernst Lengyel; Dieter Prechtel; James Resau; Katja Gauger; Anita Welk; Kristina Lindemann; Georgia Salanti; Thomas Richter; Beatrice Knudsen; George Vande Woude; Nadia Harbeck
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.
International journal of cancer. Journal international du cancer 2005;113(4):678-82.
2005: Yu-Wen Zhang; Yanli Su; Nathan Lanning; Margaret Gustafson; Nariyoshi Shinomiya; Ping Zhao; Brian Cao; Galia Tsarfaty; Ling-Mei Wang; Rick Hay; George Vande Woude
Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor.
Oncogene 2005;24(1):101-6.
2005: Chong-Feng Gao; George Vande Woude
HGF/SF-Met signaling in tumor progression.
Cell research 2005;15(1):49-51.
2004: Carrie R Graveel; Yanli Su; Julie Koeman; Ling-Mei Wang; Lino Tessarollo; Michele Fiscella; Carmen Birchmeier; Pamela Swiatek; Roderick Bronson; George Vande Woude
Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(49):17198-203.
2004: Nariyoshi Shinomiya; Chong-Feng Gao; Qian Xie; Margaret Gustafson; David J Waters; Yu-Wen Zhang; George Vande Woude
RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival.
Cancer research 2004;64(21):7962-70.
2004: Yu-Wen Zhang; Carrie R Graveel; Nariyoshi Shinomiya; George Vande Woude
Met decoys: will cancer take the bait?
Cancer cell 2004;6(1):5-6.
2004: Chong-Chou Lee; Andrew Putnam; Cindy Miranti; Margaret Gustafson; Ling-Mei Wang; George Vande Woude; Chong-Feng Gao
Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.
Oncogene 2004;23(30):5193-202.
2004: George Vande Woude; Gary J Kelloff; Raymond W Ruddon; Han-Mo Koo; Caroline C Sigman; J Carl Barrett; Robert W Day; Adam Dicker; Robert S Kerbel; David R Parkinson; William J Slichenmyer
Reanalysis of cancer drugs: old drugs, new tricks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3897-907.
2004: Gary J Kelloff; Robert C Bast; Donald S Coffey; Anthony V D'Amico; Robert S Kerbel; John W Park; Raymond W Ruddon; Gordon J S Rustin; Richard L Schilsky; Caroline C Sigman; George Vande Woude
Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3881-4.
2004: Jianqing Fan; Paul Tam; George Vande Woude; Yi Ren
Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(5):1135-40.
2003: Carmen Birchmeier; Walter Birchmeier; Ermanno Gherardi; George Vande Woude
Met, metastasis, motility and more.
Nature reviews. Molecular cell biology 2003;4(12):915-25.
2003: Nariyoshi Shinomiya; George Vande Woude
Suppression of met expression: a possible cancer treatment. Commentary re: S. J. Kim et al., reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clin. Cancer Res., 14: 5161-5170, 2003.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5085-90.
2003: Yu-Wen Zhang; Yanli Su; Olga V Volpert; George Vande Woude
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):12718-23.
2003: Rick V Hay; Brian Cao; R Scot Skinner; Ling-Mei Wang; Yanli Su; James Resau; Beatrice S Knudsen; Margaret Gustafson; Han-Mo Koo; George Vande Woude; Milton D Gross
Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3839S-44S.
2003: Xueke You; Hsiao-Man Yu; Leona Cohen-Gould; Brian Cao; Marc Symons; George Vande Woude; Beatrice S Knudsen
Regulation of migration of primary prostate epithelial cells by secreted factors from prostate stromal cells.
Experimental cell research 2003;288(2):246-56.
2003: Dean Hammond; Stephanie Carter; John McCullough; Sylvie Urbé; George Vande Woude; Michael J Clague
Endosomal dynamics of Met determine signaling output.
Molecular biology of the cell 2003;14(4):1346-54.
2003: Yu-Wen Zhang; George Vande Woude
HGF/SF-met signaling in the control of branching morphogenesis and invasion.
Journal of cellular biochemistry 2003;88(2):408-17.
2003: Arthur E Frankel; Han-Mo Koo; Stephen H Leppla; Nicholas S Duesbery; George Vande Woude
Novel protein targeted therapy of metastatic melanoma.
Current pharmaceutical design 2003;9(25):2060-6.
2002: Beatrice S Knudsen; Glenn A Gmyrek; Jennifer Inra; Douglas Scherr; E Darracott Vaughan; David M Nanus; Michael W Kattan; William L Gerald; George Vande Woude
High expression of the Met receptor in prostate cancer metastasis to bone.
Urology 2002;60(6):1113-7.
2002: Arthur E Frankel; Bayard L Powell; Nicholas S Duesbery; George Vande Woude; Stephen H Leppla
Anthrax fusion protein therapy of cancer.
Current protein & peptide science 2002;3(4):399-407.
2002: Nicholas S Duesbery; George Vande Woude
Developmental biology: an arresting activity.
Nature 2002;416(6883):804-5.
2002: Han-Mo Koo; Matthew W VanBrocklin; Mary Jane McWilliams; Stephen H Leppla; Nicholas S Duesbery; George Vande Woude
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3052-7.
2002: Chao-Nan Qian; Xiang Guo; Brian Cao; Eric J Kort; Chong-Chou Lee; Jindong Chen; Ling-Mei Wang; Wei-Yuan Mai; Hua-Qing Min; Ming-Huang Hong; George Vande Woude; James Resau; Bin Tean Teh
Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
Cancer research 2002;62(2):589-96.
2002: Yu-Wen Zhang; Ling-Mei Wang; Richard Jove; George Vande Woude
Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.
Oncogene 2002;21(2):217-26.
2002: Rick V Hay; Brian Cao; R Scot Skinner; Ling-Mei Wang; Yanli Su; James Resau; George Vande Woude; Milton D Gross
Radioimmunoscintigraphy of tumors autocrine for human met and hepatocyte growth factor/scatter factor.
Molecular imaging 2002;1(1):56-62.
2002: Rick Hay; Brian Cao; Ilan Tsarfaty; Galia Tsarfaty; James Resau; George Vande Woude
Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use.
Journal of cellular biochemistry. Supplement 2002;39():184-93.
2001: Kyle A Furge; David Kiewlich; Phuong Le; M N Vo; M Faure; Anthony R Howlett; Kenneth E Lipson; George Vande Woude; Craig Webb
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(19):10722-7.
2001: G A Gmyrek; M Walburg; Craig Webb; Hsiao-Man Yu; Xueke You; E D Vaughan; George Vande Woude; Beatrice S Knudsen
Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
The American journal of pathology 2001;159(2):579-90.
2001: Carmen M Collazo; George S Yap; G D Sempowski; K C Lusby; Lino Tessarollo; Alan Sher; George Vande Woude; Gregory A Taylor
Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection.
The Journal of experimental medicine 2001;194(2):181-8.
2001: Brian Cao; Y Su; MK Oskarsson; P Zhao; Eric J Kort; R J Fisher; L M Wang; George Vande Woude
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(13):7443-8.
2001: Dean Hammond; Sylvie Urbé; George Vande Woude; Michael J Clague
Down-regulation of MET, the receptor for hepatocyte growth factor.
Oncogene 2001;20(22):2761-70.
2001: Nicholas S Duesbery; James Resau; Craig Webb; S Koochekpour; Han-Mo Koo; Stephen H Leppla; George Vande Woude
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4089-94.
2001: Guang-Hui Xiao; M Jeffers; Alfonso Bellacosa; Yasuhiro Mitsuuchi; George Vande Woude; Joseph R Testa
Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(1):247-52.
2001: Craig Webb; George Vande Woude
Animal models for Ras-induced metastasis.
Methods in enzymology 2001;333():318-29.
2000: Jesse J Smith; Erica K. Evans; M Murakami; Mary B Moyer; M A Moseley; George Vande Woude; Sally Kornbluth
Wee1-regulated apoptosis mediated by the crk adaptor protein in Xenopus egg extracts.
The Journal of cell biology 2000;151(7):1391-400.
2000: Kyle A Furge; Y W Zhang; George Vande Woude
Met receptor tyrosine kinase: enhanced signaling through adapter proteins.
Oncogene 2000;19(49):5582-9.
2000: J H Lee; S U Han; H Cho; B Jennings; B Gerrard; M Dean; L Schmidt; Berton Zbar; George Vande Woude
A novel germ line juxtamembrane Met mutation in human gastric cancer.
Oncogene 2000;19(43):4947-53.
2000: Craig Webb; George Vande Woude
Genes that regulate metastasis and angiogenesis.
Journal of neuro-oncology 2000;50(1-2):71-87.
2000: K H Vousden; George Vande Woude
The ins and outs of p53.
Nature cell biology 2000;2(10):E178-80.
2000: M Beilmann; George Vande Woude; Hans P Dienes; Peter Schirmacher
Hepatocyte growth factor-stimulated invasiveness of monocytes.
Blood 2000;95(12):3964-9.
2000: M Firon; Miriam Shaharabany; Rom Altstock; Judith Horev; Armand Abramovici; James Resau; George Vande Woude; Ilan Tsarfaty
Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.
Oncogene 2000;19(20):2386-97.
2000: G A Taylor; E Hudson; James Resau; George Vande Woude
Regulation of P311 expression by Met-hepatocyte growth factor/scatter factor and the ubiquitin/proteasome system.
The Journal of biological chemistry 2000;275(6):4215-9.
2000: Gregory A Taylor; Carmen M Collazo; George S Yap; K Nguyen; T A Gregorio; L S Taylor; B Eagleson; L Secrest; Eileen Southon; S W Reid; Lino Tessarollo; M Bray; Daniel W McVicar; Kristin L Komschlies; Howard A Young; Christine A Biron; Alan Sher; George Vande Woude
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(2):751-5.
2000: Craig Webb; Curtis Hose; S Koochekpour; M Jeffers; MK Oskarsson; Edward A Sausville; Anne Monks; George Vande Woude
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Cancer research 2000;60(2):342-9.
1999: Han-Mo Koo; Mary Jane McWilliams; W Gregory Alvord; George Vande Woude
Ras oncogene-induced sensitization to 1-beta-D-arabinofuranosylcytosine.
Cancer research 1999;59(24):6057-62.
1999: Han-Mo Koo; George Vande Woude
Re: The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
Journal of the National Cancer Institute 1999;91(22):1969.
1999: Ilan Tsarfaty; W G Alvord; James Resau; Rom Altstock; R Lidereau; I Bieche; F Bertrand; Judith Horev; Richard L Klabansky; Iafa Keydar; George Vande Woude
Alteration of Met protooncogene product expression and prognosis in breast carcinomas.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1999;21(5):397-408.
1999: M F Jeffers; George Vande Woude
Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling.
Oncogene 1999;18(36):5120-5.
1999: Nicholas S Duesbery; George Vande Woude
Anthrax toxins.
Cellular and molecular life sciences : CMLS 1999;55(12):1599-609.
1999: S Koochekpour; M Jeffers; P H Wang; C Gong; GA Taylor; L M Roessler; Robert Stearman; James R Vasselli; William Stetler-Stevenson; William G Kaelin; W Marston Linehan; Richard D Klausner; JR Gnarra; George Vande Woude
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.
Molecular and cellular biology 1999;19(9):5902-12.
1999: Nicholas S Duesbery; George Vande Woude
Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinase.
Journal of applied microbiology 1999;87(2):289-93.
1999: Nicholas S Duesbery; Craig Webb; George Vande Woude
MEK wars, a new front in the battle against cancer.
Nature medicine 1999;5(7):736-7.
1999: S Ried; C Jäger; M Jeffers; George Vande Woude; Henner Graeff; Manfred Schmitt; Ernst Lengyel
Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
The Journal of biological chemistry 1999;274(23):16377-86.
1999: M S Murakami; T D Copeland; George Vande Woude
Mos positively regulates Xe-Wee1 to lengthen the first mitotic cell cycle of Xenopus.
Genes & development 1999;13(5):620-31.
1999: Han-Mo Koo; M Gray-Goodrich; Glenda Kohlhagen; Mary Jane McWilliams; M Jeffers; A Vaigro-Wolff; W G Alvord; Anne Monks; KD Paull; Yves Pommier; George Vande Woude
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
Journal of the National Cancer Institute 1999;91(3):236-44.
1999: D Ronen; Rom Altstock; M Firon; Leonid Mittelman; Tama Sobe; James Resau; George Vande Woude; Ilan Tsarfaty
Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(2):131-40.
1998: M Jeffers; S Koochekpour; Michele Fiscella; Bangalore Sathyanarayana; George Vande Woude
Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.
Oncogene 1998;17(21):2691-700.
1998: M Jeffers; Michele Fiscella; Craig Webb; M Anver; S Koochekpour; George Vande Woude
The mutationally activated Met receptor mediates motility and metastasis.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14417-22.
1998: Craig Webb; GA Taylor; M Jeffers; Michele Fiscella; MK Oskarsson; James Resau; George Vande Woude
Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis.
Oncogene 1998;17(16):2019-25.
1998: Nicholas S Duesbery; George Vande Woude
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
Biology of the cell / under the auspices of the European Cell Biology Organization 1998;90(6-7):461-6.
1998: GA Taylor; M Jeffers; Craig Webb; Han-Mo Koo; M Anver; K Sekiguchi; George Vande Woude
Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
Oncogene 1998;17(9):1179-83.
1998: Craig Webb; L Van Aelst; Michael Wigler; George Vande Woude
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(15):8773-8.
1998: Nicholas S Duesbery; Craig Webb; Stephen H Leppla; V M Gordon; KR Klimpel; T D Copeland; N G Ahn; MK Oskarsson; K Fukasawa; KD Paull; George Vande Woude
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science (New York, N.Y.) 1998;280(5364):734-7.
1998: L Schmidt; K Junker; Gregor Weirich; G Glenn; Peter Choyke; Irina A Lubensky; Z Zhuang; M Jeffers; George Vande Woude; H Neumann; M Walther; W Marston Linehan; Berton Zbar
Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.
Cancer research 1998;58(8):1719-22.
1998: M S Murakami; George Vande Woude
Analysis of the early embryonic cell cycles of Xenopus; regulation of cell cycle length by Xe-wee1 and Mos.
Development (Cambridge, England) 1998;125(2):237-48.
1997: S Koochekpour; M Jeffers; S Rulong; G Taylor; E Klineberg; E A Hudson; James Resau; George Vande Woude
Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Cancer research 1997;57(23):5391-8.
1997: M Beilmann; M Odenthal; W Jung; George Vande Woude; H P Dienes; Peter Schirmacher
Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes.
Blood 1997;90(11):4450-8.
1997: M Jeffers; L Schmidt; N Nakaigawa; Craig Webb; Gregor Weirich; T Kishida; Berton Zbar; George Vande Woude
Activating mutations for the met tyrosine kinase receptor in human cancer.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11445-50.
1997: K Fukasawa; Francis Wiener; George Vande Woude; Sabine Mai
Genomic instability and apoptosis are frequent in p53 deficient young mice.
Oncogene 1997;15(11):1295-302.
1997: Nicholas S Duesbery; T Choi; K D Brown; Kenneth W Wood; James Resau; K Fukasawa; Don W Cleveland; George Vande Woude
CENP-E is an essential kinetochore motor in maturing oocytes and is masked during mos-dependent, cell cycle arrest at metaphase II.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(17):9165-70.
1997: Michele Fiscella; H Zhang; S Fan; K Sakaguchi; S Shen; W E Mercer; George Vande Woude; P M O'Connor; E Appella
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6048-53.
1997: G A Taylor; R Stauber; S Rulong; E Hudson; Y Veronica Pei; George Pavlakis; James Resau; George Vande Woude
The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding.
The Journal of biological chemistry 1997;272(16):10639-45.
1997: M Jeffers; GA Taylor; K M Weidner; S Omura; George Vande Woude
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.
Molecular and cellular biology 1997;17(2):799-808.
1997: George Vande Woude; M Jeffers; J Cortner; G Alvord; Ilan Tsarfaty; James Resau
Met-HGF/SF: tumorigenesis, invasion and metastasis.
Ciba Foundation symposium 1997;212():119-30; discussion 130-2, 148-54.
1997: J Cortner; S Vande Woude; George Vande Woude
Genes involved in oncogenesis.
Advances in veterinary medicine 1997;40():51-102.
1997: M S Murakami; George Vande Woude
Mechanisms of Xenopus oocyte maturation.
Methods in enzymology 1997;283():584-600.
1997: K Fukasawa; George Vande Woude
Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Molecular and cellular biology 1997;17(1):506-18.
1996: M Jeffers; M S Rao; S Rulong; J K Reddy; V Subbarao; E Hudson; George Vande Woude; James Resau
Hepatocyte growth factor/scatter factor-Met signaling induces proliferation, migration, and morphogenesis of pancreatic oval cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(12):1805-13.
1996: Rafael A Fissore; Chang Li He; George Vande Woude
Potential role of mitogen-activated protein kinase during meiosis resumption in bovine oocytes.
Biology of reproduction 1996;55(6):1261-70.
1996: Han-Mo Koo; Anne Monks; A Mikheev; L V Rubinstein; M Gray-Goodrich; Mary Jane McWilliams; W G Alvord; H K Oie; A F Gazdar; KD Paull; Helmut Zarbl; George Vande Woude
Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes.
Cancer research 1996;56(22):5211-6.
1996: W T Matten; T D Copeland; N G Ahn; George Vande Woude
Positive feedback between MAP kinase and Mos during Xenopus oocyte maturation.
Developmental biology 1996;179(2):485-92.
1996: M Jeffers; S Rong; George Vande Woude
Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.
Journal of molecular medicine (Berlin, Germany) 1996;74(9):505-13.
1996: Craig Webb; K Lane; A P Dawson; George Vande Woude; R M Warn
C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour.
Journal of cell science 1996;109 ( Pt 9)():2371-81.
1996: GA Taylor; M Jeffers; David Largaespada; N A Jenkins; N G Copeland; George Vande Woude
Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma.
The Journal of biological chemistry 1996;271(34):20399-405.
1996: M Jeffers; S Rong; Miriam R Anver; George Vande Woude
Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Oncogene 1996;13(4):853-6.
1996: T Choi; K Fukasawa; Renping Zhou; L Tessarollo; K Borror; James Resau; George Vande Woude
The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7032-5.
1996: T Choi; S Rulong; James Resau; K Fukasawa; W Matten; R Kuriyama; S Mansour; N Ahn; George Vande Woude
Mos/mitogen-activated protein kinase can induce early meiotic phenotypes in the absence of maturation-promoting factor: a novel system for analyzing spindle formation during meiosis I.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(10):4730-5.
1996: K Fukasawa; T Choi; R Kuriyama; S Rulong; George Vande Woude
Abnormal centrosome amplification in the absence of p53.
Science (New York, N.Y.) 1996;271(5256):1744-7.
1996: M Jeffers; S Rong; George Vande Woude
Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.
Molecular and cellular biology 1996;16(3):1115-25.
1995: K Fukasawa; Renping Zhou; W T Matten; A J Armstrong; I Daar; M Oskarsson; Bangalore Sathyanarayana; L Maclvor; T G Wood; George Vande Woude
Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.
Oncogene 1995;11(8):1447-57.
1995: S Rulong; Renping Zhou; Ilan Tsarfaty; S Hughes; George Vande Woude; PEDRO PINTO DA SILVA
Immunogold labeling of oncogenic and tumor related proteins.
Microscopy research and technique 1995;31(2):159-73.
1995: S Rong; L A Donehower; M F Hansen; L Strong; Michael A Tainsky; M Jeffers; James Resau; E Hudson; Ilan Tsarfaty; George Vande Woude
Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.
Cancer research 1995;55(9):1963-70.
1995: K Fukasawa; George Vande Woude
Mos overexpression in Swiss 3T3 cells induces meiotic-like alterations of the mitotic spindle.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(8):3430-4.
1995: Katheryn A Resing; S J Mansour; A S Hermann; R S Johnson; J M Candia; K Fukasawa; George Vande Woude; Natalie G Ahn
Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS.
Biochemistry 1995;34(8):2610-20.
1995: K Fukasawa; S Rulong; James Resau; PEDRO PINTO DA SILVA; George Vande Woude
Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase.
Oncogene 1995;10(1):1-8.
1995: W T Matten; George Vande Woude
Microinjection into Xenopus oocytes.
Methods in enzymology 1995;254():458-66.
1995: J Cortner; George Vande Woude; S Rong
The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.
EXS 1995;74():89-121.
1994: K Fukasawa; M S Murakami; Donald G Blair; R Kuriyama; Tim Hunt; P Fischinger; George Vande Woude
Similarities between somatic cells overexpressing the mos oncogene and oocytes during meiotic interphase.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(10):1093-103.
1994: X M Wang; N Yew; J G Peloquin; George Vande Woude; Gary G Borisy
Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(18):8329-33.
1994: S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; George Vande Woude; Natalie G Ahn
Transformation of mammalian cells by constitutively active MAP kinase kinase.
Science (New York, N.Y.) 1994;265(5174):966-70.
1994: George Vande Woude
Embryology. On the loss of Mos.
Nature 1994;370(6484):20-1.
1994: W Jung; E Castren; M Odenthal; George Vande Woude; T Ishii; Hans P Dienes; Dan Lindholm; Peter Schirmacher
Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain.
The Journal of cell biology 1994;126(2):485-94.
1994: W Matten; I Daar; George Vande Woude
Protein kinase A acts at multiple points to inhibit Xenopus oocyte maturation.
Molecular and cellular biology 1994;14(7):4419-26.
1994: S Rong; S Segal; Miriam R Anver; James Resau; George Vande Woude
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(11):4731-5.
1994: M D Sheets; Catherine A Fox; Tim Hunt; George Vande Woude; Marvin Wickens
The 3'-untranslated regions of c-mos and cyclin mRNAs stimulate translation by regulating cytoplasmic polyadenylation.
Genes & development 1994;8(8):926-38.
1994: Ilan Tsarfaty; S Rong; James Resau; S Rulong; P P da Silva; George Vande Woude
The Met proto-oncogene mesenchymal to epithelial cell conversion.
Science (New York, N.Y.) 1994;263(5143):98-101.
1994: S Rong; George Vande Woude
Autocrine mechanism for met proto-oncogene tumorigenicity.
Cold Spring Harbor symposia on quantitative biology 1994;59():629-36.
1993: S Rong; M Jeffers; James Resau; Ilan Tsarfaty; M Oskarsson; George Vande Woude
Met expression and sarcoma tumorigenicity.
Cancer research 1993;53(22):5355-60.
1993: S Rong; M Oskarsson; D Faletto; Ilan Tsarfaty; James Resau; T Nakamura; E Rosen; R F Hopkins; George Vande Woude
Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(7):563-9.
1993: J Posada; N Yew; Natalie G Ahn; George Vande Woude; Jonathan A Cooper
Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro.
Molecular and cellular biology 1993;13(4):2546-53.
1993: I Daar; N Yew; George Vande Woude
Inhibition of mos-induced oocyte maturation by protein kinase A.
The Journal of cell biology 1993;120(5):1197-202.
1993: N Yew; M Strobel; George Vande Woude
Mos and the cell cycle: the molecular basis of the transformed phenotype.
Current opinion in genetics & development 1993;3(1):19-25.
1993: D L Faletto; D R Kaplan; D O Halverson; E M Rosen; George Vande Woude
Signal transduction in c-met mediated motogenesis.
EXS 1993;65():107-30.
1992: Richard S Paules; J Resnick; A B Kasenally; M K Ernst; P Donovan; George Vande Woude
Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
Oncogene 1992;7(12):2489-98.
1992: T E Kmiecik; Jonathan Keller; E Rosen; George Vande Woude
Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells.
Blood 1992;80(10):2454-7.
1992: S Rong; M Bodescot; D Blair; J Dunn; T Nakamura; K Mizuno; M Park; A Chan; S Aaronson; George Vande Woude
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Molecular and cellular biology 1992;12(11):5152-8.
1992: Ilan Tsarfaty; James Resau; S Rulong; Iafa Keydar; D L Faletto; George Vande Woude
The met proto-oncogene receptor and lumen formation.
Science (New York, N.Y.) 1992;257(5074):1258-61.
1992: Renping Zhou; I Daar; D K Ferris; G White; Richard S Paules; George Vande Woude
pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells.
Molecular and cellular biology 1992;12(8):3583-9.
1992: D L Faletto; Ilan Tsarfaty; T E Kmiecik; M Gonzatti; T Suzuki; George Vande Woude
Evidence for non-covalent clusters of the c-met proto-oncogene product.
Oncogene 1992;7(6):1149-57.
1992: N Schulz; George Vande Woude
"A transgenic mouse model for men 2".
AIDS research and human retroviruses 1992;8(5):820-3.
1992: O Higuchi; K Mizuno; George Vande Woude; T Nakamura
Expression of c-met proto-oncogene in COS cells induces the signal transducing high-affinity receptor for hepatocyte growth factor.
FEBS letters 1992;301(3):282-6.
1992: N Yew; M L Mellini; George Vande Woude
Meiotic initiation by the mos protein in Xenopus.
Nature 1992;355(6361):649-52.
1992: N Schulz; F Propst; M P Rosenberg; R I Linnoila; Richard S Paules; R Kovatch; Y Ogiso; George Vande Woude
Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome.
Cancer research 1992;52(2):450-5.
1992: N Schulz; F Propst; M M Rosenberg; R I Linnoila; Richard S Paules; D Schulte; George Vande Woude
Patterns of neoplasia in c-mos transgenic mice and their relevance to multiple endocrine neoplasia.
Henry Ford Hospital medical journal 1992;40(3-4):307-11.
1991: I O Daar; G A White; S M Schuh; Douglass K Ferris; George Vande Woude
tpr-met oncogene product induces maturation-producing factor activation in Xenopus oocytes.
Molecular and cellular biology 1991;11(12):5985-91.
1991: Alfred G Knudson; George Vande Woude; S H Friend; W K Cavenee; G M Brodeur
Developmental genetics and childhood cancer. AACR special conference in cancer research.
Cancer research 1991;51(19):5435-9.
1991: I Daar; A R Nebreda; N Yew; P Sass; Richard S Paules; E Santos; Michael Wigler; George Vande Woude
The ras oncoprotein and M-phase activity.
Science (New York, N.Y.) 1991;253(5015):74-6.
1991: I Daar; Richard S Paules; George Vande Woude
A characterization of cytostatic factor activity from Xenopus eggs and c-mos-transformed cells.
The Journal of cell biology 1991;114(2):329-35.
1991: Renping Zhou; R L Shen; PEDRO PINTO DA SILVA; George Vande Woude
In vitro and in vivo characterization of pp39mos association with tubulin.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1991;2(5):257-65.
1991: K Okazaki; Nobuaki Furuno; N Watanabe; Y Ikawa; George Vande Woude; Noriyuki Sagata
Correlation between physiological and transforming activities of the c-mos proto-oncogene product and identification of an essential Mos domain for these activities.
Japanese journal of cancer research : Gann 1991;82(3):250-3.
1991: Donald Bottaro; Jeffrey S Rubin; D L Faletto; A M Chan; T E Kmiecik; George Vande Woude; Stuart A Aaronson
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.
Science (New York, N.Y.) 1991;251(4995):802-4.
1991: Renping Zhou; M Oskarsson; Richard S Paules; N Schulz; D Cleveland; George Vande Woude
Ability of the c-mos product to associate with and phosphorylate tubulin.
Science (New York, N.Y.) 1991;251(4994):671-5.
1991: N Yew; M Oskarsson; I Daar; Donald G Blair; George Vande Woude
mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.
Molecular and cellular biology 1991;11(2):604-10.
1991: I Daar; Renping Zhou; R L Shen; A Nebreda; M Oskarsson; E Santos; P P da Silva; Y Masui; George Vande Woude
Mos and Ras: two oncoproteins that display M-phase activity.
Cold Spring Harbor symposia on quantitative biology 1991;56():477-88.
1990: F Propst; M P Rosenberg; L C Cork; R M Kovatch; S Rauch; Heiner Westphal; J Khillan; N T Schulz; P E Neumann; George Vande Woude; P E Newmann
Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(24):9703-7.
1990: J R Testa; M Park; D G Blair; A Kalbakji; K Arden; George Vande Woude
Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.
Oncogene 1990;5(10):1565-71.
1990: A Iyer; T E Kmiecik; M Park; I Daar; D Blair; K J Dunn; P Sutrave; J N Ihle; M Bodescot; George Vande Woude
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(2):87-95.
1990: George Vande Woude; E P Reddy
Oncogenes and the Nobel Prize.
Oncogene 1990;5(1):3.
1990: George Vande Woude; Roberto Buccione; I Daar; John J Eppig; M Oskarsson; Richard S Paules; N Sagata; N Yew
mos proto-oncogene function.
Ciba Foundation symposium 1990;150():147-60; discussion 160-2.
1989: N Watanabe; George Vande Woude; Y Ikawa; N Sagata
Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs.
Nature 1989;342(6249):505-11.
1989: N Sagata; N Watanabe; George Vande Woude; Y Ikawa
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.
Nature 1989;342(6249):512-8.
1989: N Sagata; I Daar; M Oskarsson; S D Showalter; George Vande Woude
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation.
Science (New York, N.Y.) 1989;245(4918):643-6.
1989: F Propst; George Vande Woude; N A Jenkins; N G Copeland; B K Lee; P A Hunt; E M Eicher
The Mos proto-oncogene maps near the centromere on mouse chromosome 4.
Genomics 1989;5(1):118-23.
1989: Richard S Paules; Roberto Buccione; R C Moschel; George Vande Woude; John J Eppig
Mouse Mos protooncogene product is present and functions during oogenesis.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(14):5395-9.
1988: N Sagata; M Oskarsson; T Copeland; J Brumbaugh; George Vande Woude
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.
Nature 1988;335(6190):519-25.
1988: J R Testa; N Z Parsa; M M Le Beau; George Vande Woude
Localization of the proto-oncogene MOS to 8q11-q12 by in situ chromosomal hybridization.
Genomics 1988;3(1):44-7.
1988: F Propst; M P Rosenberg; George Vande Woude
Proto-oncogene expression in germ cell development.
Trends in genetics : TIG 1988;4(7):183-7.
1988: M Park; J R Testa; D G Blair; N Z Parsa; George Vande Woude
Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(8):2667-71.
1988: E Keshet; M P Rosenberg; J A Mercer; F Propst; George Vande Woude; N A Jenkins; N G Copeland
Developmental regulation of ovarian-specific Mos expression.
Oncogene 1988;2(3):235-40.
1988: F Propst; M P Rosenberg; M K Oskarsson; L B Russell; M C Nguyen-Huu; J Nadeau; N A Jenkins; N G Copeland; George Vande Woude
Genetic analysis and developmental regulation of testis-specific RNA expression of Mos, Abl, actin and Hox-1.4.
Oncogene 1988;2(3):227-33.
1988: M Schmidt; M K Oskarsson; J K Dunn; Donald G Blair; S Hughes; F Propst; George Vande Woude
Chicken homolog of the mos proto-oncogene.
Molecular and cellular biology 1988;8(2):923-9.
1988: M Gonzatti-Haces; A Seth; M Park; T Copeland; S Oroszlan; George Vande Woude
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(1):21-5.
1987: J S Khillan; M K Oskarsson; F Propst; T Kuwabara; George Vande Woude; Heiner Westphal
Defects in lens fiber differentiation are linked to c-mos overexpression in transgenic mice.
Genes & development 1987;1(10):1327-35.
1987: George Vande Woude; Donald G Blair; M L McGeady; T Wood; F Propst
Properties of the mouse mos proto-oncogene locus.
Haematologica 1987;72(6 Suppl):3-5.
1987: M Dean; C Kozak; J Robbins; R Callahan; S O'Brien; George Vande Woude
Chromosomal localization of the met proto-oncogene in the mouse and cat genome.
Genomics 1987;1(2):167-73.
1987: M Dean; P O'Connell; M Leppert; M Park; J A Amos; D G Phillips; Raymond White; George Vande Woude
Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis.
The Journal of pediatrics 1987;111(4):490-5.
1987: M Park; M Dean; K Kaul; M J Braun; Matthew A Gonda; George Vande Woude
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(18):6379-83.
1987: A Seth; E Priel; George Vande Woude
Nucleoside triphosphate-dependent DNA-binding properties of mos protein.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(11):3560-4.
1987: F Propst; M P Rosenberg; A Iyer; K Kaul; George Vande Woude
c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types.
Molecular and cellular biology 1987;7(5):1629-37.
1987: Michael A Tainsky; F L Shamanski; D Blair; George Vande Woude
Human recipient cell for oncogene transfection studies.
Molecular and cellular biology 1987;7(3):1280-4.
1987: Francis S Collins; Mitchell L Drumm; J L Cole; W K Lockwood; George Vande Woude; Michael C Iannuzzi
Construction of a general human chromosome jumping library, with application to cystic fibrosis.
Science (New York, N.Y.) 1987;235(4792):1046-9.
1987: M Dean; M Park; George Vande Woude
Characterization of the rearranged tpr-met oncogene breakpoint.
Molecular and cellular biology 1987;7(2):921-4.
1987: M Dean; M Park; K Kaul; D Blair; George Vande Woude
Activation of the met proto-oncogene in a human cell line.
Haematology and blood transfusion 1987;31():464-8.
1987: P O'Connell; M Leppert; Y Nakamura; M Dean; M Park; George Vande Woude; M Farrall; B Wainwright; R Williamson; G M Lathrop
DNA markers for the cystic fibrosis locus.
Progress in clinical and biological research 1987;254():127-37.
1986: Raymond White; M Leppert; P O'Connell; Y Nakamura; S Woodward; M Hoff; J Herbst; M Dean; George Vande Woude; G M Lathrop
Further linkage data on cystic fibrosis: the Utah Study.
American journal of human genetics 1986;39(6):694-8.
1986: C Jhappan; George Vande Woude; T S Robins
Transduction of host cellular sequences by a retroviral shuttle vector.
Journal of virology 1986;60(2):750-3.
1986: Donald G Blair; M K Oskarsson; A Seth; K J Dunn; M Dean; M Zweig; Michael A Tainsky; George Vande Woude
Analysis of the transforming potential of the human homolog of mos.
Cell 1986;46(5):785-94.
1986: M L McGeady; T G Wood; jacob valentine maizel; George Vande Woude
Sequences upstream from the mouse c-mos oncogene may function as a transcription termination signal.
DNA (Mary Ann Liebert, Inc.) 1986;5(4):289-98.
1986: M Park; M Dean; C S Cooper; M Schmidt; S J O'Brien; D G Blair; George Vande Woude
Mechanism of met oncogene activation.
Cell 1986;45(6):895-904.
1986: A Seth; P Lapis; George Vande Woude; T Papas
High-level expression vectors to synthesize unfused proteins in Escherichia coli.
Gene 1986;42(1):49-57.
1986: George Vande Woude; M Dean; M Gonzatti-Haces; A Iyer; K Kaul; T Robins; M Park; Donald G Blair
Properties of the met oncogene.
Gene amplification and analysis 1986;4():239-52.
1986: A J Hapel; George Vande Woude; Hugh D Campbell; Ian G Young; T Robins
Generation of an autocrine leukaemia using a retroviral expression vector carrying the interleukin-3 gene.
Lymphokine research 1986;5(4):249-54.
1986: M Park; M Gonzatti-Haces; M Dean; Donald G Blair; J R Testa; D D Bennett; T Copeland; S Oroszlan; George Vande Woude
The met oncogene: a new member of the tyrosine kinase family and a marker for cystic fibrosis.
Cold Spring Harbor symposia on quantitative biology 1986;51 Pt 2():967-75.
1986: M Gonzatti-Haces; M Park; M Dean; Donald G Blair; George Vande Woude
The human met oncogene is a member of the tyrosine kinase family.
Princess Takamatsu symposia 1986;17():221-32.
1985: M Dean; M Park; M M Le Beau; T S Robins; M O Diaz; J D Rowley; D G Blair; George Vande Woude
The human met oncogene is related to the tyrosine kinase oncogenes.
Nature 1985;318(6044):385-8.
1985: Raymond White; S Woodward; M Leppert; P O'Connell; M Hoff; J Herbst; J M Lalouel; M Dean; George Vande Woude
A closely linked genetic marker for cystic fibrosis.
Nature 1985;318(6044):382-4.
1985: A Seth; George Vande Woude
Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.
Journal of virology 1985;56(1):144-52.
1985: F Propst; George Vande Woude
Expression of c-mos proto-oncogene transcripts in mouse tissues.
Nature 1985;315(6019):516-8.
1984: T G Wood; M L McGeady; B M Baroudy; Donald G Blair; George Vande Woude
Mouse c-mos oncogene activation is prevented by upstream sequences.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(24):7817-21.
1984: F Propst; George Vande Woude
A novel transposon-like repeat interrupted by an LTR element occurs in a cluster of B1 repeats in the mouse c-mos locus.
Nucleic acids research 1984;12(22):8381-92.
1984: C S Cooper; M Park; D G Blair; Michael A Tainsky; K Huebner; C M Croce; George Vande Woude
Molecular cloning of a new transforming gene from a chemically transformed human cell line.
Nature 1984;311(5981):29-33.
1984: Michael A Tainsky; C S Cooper; B C Giovanella; George Vande Woude
An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells.
Science (New York, N.Y.) 1984;225(4662):643-5.
1984: C S Cooper; Donald G Blair; M K Oskarsson; Michael A Tainsky; L A Eader; George Vande Woude
Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines.
Cancer research 1984;44(1):1-10.
1983: T G Wood; M L McGeady; Donald G Blair; George Vande Woude
Long terminal repeat enhancement of v-mos transforming activity: identification of essential regions.
Journal of virology 1983;46(3):726-36.
1983: M L McGeady; C Jhappan; R Ascione; George Vande Woude
In vitro methylation of specific regions of the cloned Moloney sarcoma virus genome inhibits its transforming activity.
Molecular and cellular biology 1983;3(3):305-14.
1983: Donald G Blair; C S Cooper; M K Oskarsson; L A Eader; George Vande Woude
Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
Progress in clinical and biological research 1983;119():79-90.
1982: Donald G Blair; C S Cooper; M K Oskarsson; L A Eader; George Vande Woude
New method for detecting cellular transforming genes.
Science (New York, N.Y.) 1982;218(4577):1122-5.
1982: D Swan; M Oskarsson; D Keithley; F H Ruddle; P D'Eustachio; George Vande Woude
Chromosomal localization of the Moloney sarcoma virus mouse cellular (c-mos) sequence.
Journal of virology 1982;44(2):752-4.
1982: R Watson; M Oskarsson; George Vande Woude
Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(13):4078-82.
1982: W G Robey; W J Kuenzel; George Vande Woude; P J Fischinger
Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
Cancer research 1982;42(7):2523-9.
1982: B Levinson; G Khoury; George Vande Woude; P Gruss
Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus.
Nature 1982;295(5850):568-72.
1982: R J Watson; George Vande Woude
DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I.
Nucleic acids research 1982;10(3):979-91.
1982: S E Straus; J Owens; W T Ruyechan; H E Takiff; T A Casey; George Vande Woude; J Hay
Molecular cloning and physical mapping of varicella-zoster virus DNA.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(4):993-7.
1982: H L Robinson; George Vande Woude
The genetic basis of retroviral-induced transformation.
Current topics in microbiology and immunology 1982;98():11-6.
1981: K J Denniston; M J Madden; Lynn Enquist; George Vande Woude
Characterization of coliphage lambda hybrids carrying DNA fragments from Herpes simplex virus type 1 defective interfering particles.
Gene 1981;15(4):365-78.
1981: S E Straus; H S Aulakh; W T Ruyechan; J Hay; T A Casey; George Vande Woude; J Owens; H A Smith
Structure of varicella-zoster virus DNA.
Journal of virology 1981;40(2):516-25.
1981: Donald G Blair; M Oskarsson; T G Wood; W L McClements; P J Fischinger; George Vande Woude
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis.
Science (New York, N.Y.) 1981;212(4497):941-3.
1981: Donald G Blair; M Oskarsson; W L McClements; George Vande Woude
The long terminal repeat of Moloney sarcoma provirus enhances transformation.
Haematology and blood transfusion 1981;26():460-6.
1981: W L McClements; R Dhar; Donald G Blair; L Enquist; M Oskarsson; George Vande Woude
The long terminal repeat of Moloney sarcoma provirus.
Cold Spring Harbor symposia on quantitative biology 1981;45 Pt 2():699-705.
1981: R J Watson; M Sullivan; George Vande Woude
Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component.
Journal of virology 1981;37(1):431-44.
1980: W L McClements; Lynn Enquist; M Oskarsson; M Sullivan; George Vande Woude
Frequent site-specific deletion of coliphage lambda murine sarcoma virus recombinants and its use in the identification of a retrovirus integration site.
Journal of virology 1980;35(2):488-97.
1980: R Dhar; W L McClements; Lynn Enquist; George Vande Woude
Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(7):3937-41.
1980: Donald G Blair; W L McClements; M K Oskarsson; P J Fischinger; George Vande Woude
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3504-8.
1980: A L Boyd; L Enquist; George Vande Woude; B Hampar
Activation of mouse retrovirus by herpes simplex virus type 1 cloned DNA fragments.
Virology 1980;103(1):228-31.
1980: C J Sherr; L A Fedele; M Oskarsson; J Maizel; George Vande Woude
Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus.
Journal of virology 1980;34(1):200-12.
1980: M Oskarsson; W L McClements; Donald G Blair; J V Maizel; George Vande Woude
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus.
Science (New York, N.Y.) 1980;207(4436):1222-4.
1980: George Vande Woude; M Oskarsson; W L McClements; Lynn Enquist; Donald G Blair; P J Fischinger; J V Maizel; M Sullivan
Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():735-45.
1979: Lynn Enquist; George Vande Woude; M Wagner; J R Smiley; W C Summers
Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus.
Gene 1979;7(3-4):335-42.
1979: George Vande Woude; M Oskarsson; Lynn Enquist; S Nomura; M Sullivan; P J Fischinger
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(9):4464-8.
1979: Lynn Enquist; M J Madden; P Schiop-Stanley; George Vande Woude
Cloning of herpes simplex type 1 DNA fragments in a bacteriophage lambda vector.
Science (New York, N.Y.) 1979;203(4380):541-4.
1978: M K Oskarsson; J H Elder; J W Gautsch; R A Lerner; George Vande Woude
Chemical determination of the m1 Moloney sarcoma virus pP60gag gene order: evidence for unique peptides in the carboxy terminus of the polyprotein.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(10):4694-8.
1978: B J Graham; Z Bengali; George Vande Woude
Physical map of the origin of defective DNA in herpes simplex virus type 1 DNA.
Journal of virology 1978;25(3):878-87.
1978: G Yonuschot; D Helman; G Mushrush; George Vande Woude; G Robey
Terbium as a solid-state probe for RNA.
Bioinorganic chemistry 1978;8(5):405-18.
1978: G Yonuschot; G Robey; G W Mushrush; D Helman; George Vande Woude
Measurement of binding of terbium to DNA.
Bioinorganic chemistry 1978;8(5):397-404.
1977: M K Oskarsson; C W Long; W G Robey; M A Scherer; George Vande Woude
Phosphorylation and nucleic acid binding properties of m1 Moloney murine sarcoma virus-specific pP60gag.
Journal of virology 1977;23(1):196-204.
1977: W G Robey; M K Oskarsson; R B Naso; R B Arlinghaus; D K Haapala; George Vande Woude; P J Fischinger
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60.
Cell 1977;10(1):79-89.
1976: W G Robey; B J Graham; C L Harris; M J Madden; G R Pearson; George Vande Woude
Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines.
The Journal of general virology 1976;32(1):51-62.
1975: George Vande Woude; W G Robey; M K Oskarsson; D K Haapala; P J Fischinger; R B Naso; R B Arlinghaus
Properties of Moloney sarcoma virus-specific p60 and its detection in transformed cells.
Bibliotheca haematologica 1975;(43):125-7.
1975: R Ascione; J Smida; W G Robey; George Vande Woude
A cell-free mammalian protein-synthesizing system stimulated by RNA from avian myeloblastosis virus.
Biochimica et biophysica acta 1975;395(4):509-24.
1975: M K Oskarsson; W G Robey; C L Harris; P J Fischinger; D K Haapala; George Vande Woude
A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(6):2380-4.
1975: J A Simonds; W G Robey; B J Graham; H Oie; George Vande Woude
Purification of herpesvirus saimiri and properties of the viral DNA.
Archives of virology 1975;49(2-3):249-59.
1974: A P Andrese; George Vande Woude; M J Walling
Ultrastructural study of herpes simplex virus infection of mouse cells chronically producing Rauscher leukemia virus.
Journal of the National Cancer Institute 1974;53(4):1169-73.
1974: W D Holder; W G Robey; George Vande Woude
Activation of a C-type virus from the human carcinoma cell line HBT-3 by iododeoxyuridine and testosterone.
Nature 1974;249(459):759-62.
1974: J B Swaney; George Vande Woude; H L Bachrach
Sodium dodecylsulfate-dependent anomalies in gel electrophoresis: alterations in the banding patterns of foot-and-mouth disease virus polypeptides.
Analytical biochemistry 1974;58(2):337-46.
1974: George Vande Woude; R Ascione
Translation products of foot-and-mouth disease virus-infected baby hamster kidney cells.
Archiv für die gesamte Virusforschung 1974;45(3):259-71.
1974: J Smida; V Smidova; A Andrese; George Vande Woude
Search for oncogenicity of type C particles released from mammalian cell lines transformed by avian Oncornaviruses.
Neoplasma 1974;21(6):609-18.
1973: H L Bachrach; J B Swaney; George Vande Woude
Isolation of the structural polypeptides of foot-and-mouth disease virus and analysis of their C-terminal sequences.
Virology 1973;52(2):520-8.
1972: George Vande Woude; J B Swaney; H L Bachrach
Chemical and physical properties of foot-and-mouth disease virus: a comparison with Maus Elberfeld virus.
Biochemical and biophysical research communications 1972;48(5):1222-9.
1971: R Ascione; George Vande Woude
Ribosomal factors effecting the stimulation of cell-free protein synthesis in the prescence of foot-and-mouth disease virus ribonucleic acid.
Biochemical and biophysical research communications 1971;45(1):14-21.
1971: George Vande Woude; H L Bachrach
Number and molecular weights of foot-and-mouth disease virus capsid proteins and the effects of maleylation.
Journal of virology 1971;7(2):250-9.
1970: George Vande Woude; J Polatnick; R Ascione
Foot-and-mouth disease virus-induced alterations of baby hamster kidney cell macromolecular biosynthesis: inhibition of ribonucleic acid methylation and stimulation of ribonucleic acid synthesis.
Journal of virology 1970;5(4):458-63.
1969: R Ascione; George Vande Woude
Inhibition of host cell ribosomal ribonucleic acid methylation by foot-and-mouth disease virus.
Journal of virology 1969;4(5):727-37.
1968: H L Bachrach; George Vande Woude
Amino acid composition and C-terminal sequence of foot-and-mouth disease virus protein.
Virology 1968;34(2):282-9.
1968: George Vande Woude; H L Bachrach
Evidence for a single structural polypeptide in foot-and-mouth disease virus.
Archiv für die gesamte Virusforschung 1968;23(4):353-61.
1968: J Polatnick; George Vande Woude; R B Arlinghaus
Changes in protein and nucleic acid metabolism in baby hamster kidney cells infected with foot-and-mouth disease virus.
Archiv für die gesamte Virusforschung 1968;23(3):218-26.
1967: George Vande Woude; R B Arlinghaus; J Polatnick
Inhibition of ribonucleic acid methylation in the foot-and-mouth disease virus-infected host cell.
Biochemical and biophysical research communications 1967;29(4):483-9.
1967: George Vande Woude
The inactivation of foot-and-mouth disease virus at ionic-strength dependent isoelectric points.
Virology 1967;31(3):436-41.
1967: George Vande Woude; R Trautman; H L Bachrach
The influence of the host cell, ionic strength and chymotrypsin on foot-and-mouth disease virus electrophoretic mobility.
Archiv für die gesamte Virusforschung 1967;20(1):71-80.
1966: R B Arlinghaus; J Polatnick; George Vande Woude
Studies on foot-and-mouth disease virus ribonucleic acid synthesis.
Virology 1966;30(3):541-50.
1965: George Vande Woude; F F Davis
The fractionation of histones by electrophoresis in polyacrylamide gel.
Analytical biochemistry 1965;12(3):444-51.
1963: George Vande Woude; F F Davis
BARRIER ELECTROPHORESIS: A NEW ELECTROPHORESIS TECHNIQUE.
Analytical biochemistry 1963;6():240-50.